中国骨质疏松杂志
中國骨質疏鬆雜誌
중국골질소송잡지
CHINESE JOURNAL OF OSTEOPOROSIS
2015年
4期
467-471,498
,共6页
李程%裴福兴%杨静%沈彬%周宗科
李程%裴福興%楊靜%瀋彬%週宗科
리정%배복흥%양정%침빈%주종과
依替二膦酸锶%依替二膦酸二钠%二氯化锶%骨组织生物力学%骨质疏松%SD大鼠
依替二膦痠鍶%依替二膦痠二鈉%二氯化鍶%骨組織生物力學%骨質疏鬆%SD大鼠
의체이련산송%의체이련산이납%이록화송%골조직생물역학%골질소송%SD대서
Strontium etidronate%Didodium etidronate%Strontium chloride%Bone biomechanics%Osteoporosis%SD rats
目的:观察新合成的抗骨质疏松化合物依替二膦酸锶对骨组织生物力学的影响。方法以去势SD大鼠为基础,对依替二膦酸锶、依替二膦酸二钠和二氯化锶以及不同剂量依替二膦酸锶对大鼠股骨及腰椎生物力学性质的影响进行动态观察和比较。结果依替二膦酸二钠治疗12 w后其股骨的最大负荷升高9.5%(P=0.028),并且其差异表现出统计学意义;依替二膦酸锶治疗组8 w、12 w后,其股骨的最大负荷分别升高21.9%和22.3%(P=0.020,P=0.047),且均表现出统计学差异。3种不同药物治疗下,股骨于最大负荷下的变形没有明显变化。所有治疗组大鼠椎体的最大负荷均高于去势对照组。依替二膦酸锶治疗12 w 后,其椎体的最大负荷明显升高( P =0.016),并表现出统计学差异。观察到100 mg/( kg? d )和150 mg/(kg?d)治疗组干预8 w后,其股骨最大负荷升高(P=0.035,P=0.042),并表现出统计学意义;椎体最大负荷于也明显升高(P=0.018),并表现出统计学意义。大鼠股骨他椎体于最大负荷时的椎体变形并未表现出统计学意义。实验发现依替二膦酸锶与依替二膦酸二钠相比,对去势大鼠腰椎和股骨生物力学性质的影响更为明显。其干预后去势大鼠骨组织生物力学性质的出现更早,且其升高的幅度也较高。50 mg/(kg?d)、100 mg/(kg?d)和150 mg/(kg?d)3种不同剂量的依替二膦酸锶均能有效地改善去势大鼠椎体和股骨的生物力学性质,且其改善生物力学性质的能力无明显差异。结论新化合物中的骨吸收抑制物依替二膦酸和骨形成促进物锶进入大鼠体内后,两者的生物学效应可能存在互补性。
目的:觀察新閤成的抗骨質疏鬆化閤物依替二膦痠鍶對骨組織生物力學的影響。方法以去勢SD大鼠為基礎,對依替二膦痠鍶、依替二膦痠二鈉和二氯化鍶以及不同劑量依替二膦痠鍶對大鼠股骨及腰椎生物力學性質的影響進行動態觀察和比較。結果依替二膦痠二鈉治療12 w後其股骨的最大負荷升高9.5%(P=0.028),併且其差異錶現齣統計學意義;依替二膦痠鍶治療組8 w、12 w後,其股骨的最大負荷分彆升高21.9%和22.3%(P=0.020,P=0.047),且均錶現齣統計學差異。3種不同藥物治療下,股骨于最大負荷下的變形沒有明顯變化。所有治療組大鼠椎體的最大負荷均高于去勢對照組。依替二膦痠鍶治療12 w 後,其椎體的最大負荷明顯升高( P =0.016),併錶現齣統計學差異。觀察到100 mg/( kg? d )和150 mg/(kg?d)治療組榦預8 w後,其股骨最大負荷升高(P=0.035,P=0.042),併錶現齣統計學意義;椎體最大負荷于也明顯升高(P=0.018),併錶現齣統計學意義。大鼠股骨他椎體于最大負荷時的椎體變形併未錶現齣統計學意義。實驗髮現依替二膦痠鍶與依替二膦痠二鈉相比,對去勢大鼠腰椎和股骨生物力學性質的影響更為明顯。其榦預後去勢大鼠骨組織生物力學性質的齣現更早,且其升高的幅度也較高。50 mg/(kg?d)、100 mg/(kg?d)和150 mg/(kg?d)3種不同劑量的依替二膦痠鍶均能有效地改善去勢大鼠椎體和股骨的生物力學性質,且其改善生物力學性質的能力無明顯差異。結論新化閤物中的骨吸收抑製物依替二膦痠和骨形成促進物鍶進入大鼠體內後,兩者的生物學效應可能存在互補性。
목적:관찰신합성적항골질소송화합물의체이련산송대골조직생물역학적영향。방법이거세SD대서위기출,대의체이련산송、의체이련산이납화이록화송이급불동제량의체이련산송대대서고골급요추생물역학성질적영향진행동태관찰화비교。결과의체이련산이납치료12 w후기고골적최대부하승고9.5%(P=0.028),병차기차이표현출통계학의의;의체이련산송치료조8 w、12 w후,기고골적최대부하분별승고21.9%화22.3%(P=0.020,P=0.047),차균표현출통계학차이。3충불동약물치료하,고골우최대부하하적변형몰유명현변화。소유치료조대서추체적최대부하균고우거세대조조。의체이련산송치료12 w 후,기추체적최대부하명현승고( P =0.016),병표현출통계학차이。관찰도100 mg/( kg? d )화150 mg/(kg?d)치료조간예8 w후,기고골최대부하승고(P=0.035,P=0.042),병표현출통계학의의;추체최대부하우야명현승고(P=0.018),병표현출통계학의의。대서고골타추체우최대부하시적추체변형병미표현출통계학의의。실험발현의체이련산송여의체이련산이납상비,대거세대서요추화고골생물역학성질적영향경위명현。기간예후거세대서골조직생물역학성질적출현경조,차기승고적폭도야교고。50 mg/(kg?d)、100 mg/(kg?d)화150 mg/(kg?d)3충불동제량적의체이련산송균능유효지개선거세대서추체화고골적생물역학성질,차기개선생물역학성질적능력무명현차이。결론신화합물중적골흡수억제물의체이련산화골형성촉진물송진입대서체내후,량자적생물학효응가능존재호보성。
Objective To investigate the effect of the new compound strontium etidronate on bone biomechanics.Methods Using ovariectomized SD rats, the effect of didodium etidronate, strontium chloride, and different doses strontium etidronate on the femoral and vertebral bone biomechanical property was dynamically observed and compared.Results The rat femoral Max load improved by 9.5%after 12-week intervention of didodium etidronate (P=0.028), and the result was statistical different.The rat femoral Max load improved by 21.9% and 22.3%, respectively, after 8-and 12-week intervention of strontium etidronate ( P=0.020, P=0.047), and the results were statistical different.The femoral deformation under the Max load showed no different change when intervened with the above three substances.The Max load of the vertebrae in all treatment groups was higher than that in OVX group.The Max load of the vertebrae improved significantly after 12-week treatment of strontium etidronate (P=0.016). Both the femoral Max load and the lumbar Max load improved in 100 mg/kg?d (P=0.035, P=0.042) and 150 mg/kg?d (P=0.018) strontium etidronate treatment groups in 8 weeks.No statistical difference of femoral and lumbar deformation was shown under the Max load.The lumbar and femoral biomechanics improved more in strontium etidronate group than in didodium etidronate group.and the biomechanical improvement appeared earlier and more.Strontium etidronate of different doses (50 mg/kg?d, 100 mg/kg?d, and 150 mg/kg?d) improved the lumbar and femoral biomechanics of ovariectomized rats effectively.The efficacy among the three different doses showed no obvious difference.Conclusion The new compounds, etidronate for inhibition of bone resorption and strontium for stimulation of bone formation, show complement biological effect in vivo.